Your browser doesn't support javascript.
loading
The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease.
Cuadrado, Antonio; Moreno-Murciano, Paz; Pedraza-Chaverri, José.
Affiliation
  • Cuadrado A; Instituto de Investigaciones Biomédicas Alberto Sols UAM-CSIC, Ciber de Enfermedades Neurodegenerativas, Departamento de Bioquímica, Facultad de Medicina Universidad Autónoma de Madrid, Madrid, Spain. antonio.cuadrado@uam.es
Expert Opin Ther Targets ; 13(3): 319-29, 2009 Mar.
Article in En | MEDLINE | ID: mdl-19236154
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / NF-E2-Related Factor 2 / Antiparkinson Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Expert Opin Ther Targets Journal subject: TERAPEUTICA Year: 2009 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / NF-E2-Related Factor 2 / Antiparkinson Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Expert Opin Ther Targets Journal subject: TERAPEUTICA Year: 2009 Document type: Article Affiliation country: Country of publication: